Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Roadmap Concept in Chronic Hepatitis B Treatment”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Post-approval studies (Phase 4)Study completedNCT01379508
What this trial is testing

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 241
Not applicableStudy completedNCT01958229
What this trial is testing

Efficacy Study of Telbivudine in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BRoadmap Concept in Chronic Hepatitis B Treatment24-week PCR Negativity of Telbivudine+2 more
National Taiwan University Hospital 23
Post-approval studies (Phase 4)Study completedNCT00651209
What this trial is testing

A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 105